You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liposomal amphotericin B

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Disseminated Histoplasma Capsulatum Infection, AIDS and Infections, Immunosuppression Trial (Liposomal Amphotericin B)

Not yet recruiting
  • Disseminated Histoplasma Capsulatum Infection
  • +3 more
  • Liposomal Amphotericin B
  • (no location specified)
Apr 12, 2023

Leishmaniasis Trial in Beer Sheva (Topical Amphotericin-B 0.4% liposomal gel)

Completed
  • Leishmaniasis
  • Topical Amphotericin-B 0.4% liposomal gel
  • Beer Sheva, Israel
    Soroka University Medical Center
Mar 12, 2022

Mucormycosis; Pulmonary (Etiology) Trial in Chandigarh (Posaconazole 600 mg followed by posaconazole 300 mg once daily,

Recruiting
  • Mucormycosis; Pulmonary (Etiology)
  • Posaconazole 600 mg followed by posaconazole 300 mg once daily
  • Liposomal Amphotericin B
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Jul 19, 2022

Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous Trial in Brasilia (Miltefosine 50mg, Pentoxifylline 400mg, Liposomal

Recruiting
  • Leishmaniasis; Brazilian
  • Leishmaniasis, Mucocutaneous
  • Miltefosine 50mg
  • +2 more
  • Brasilia, DF, Brazil
    Hospital Universitario de Brasilia
Sep 13, 2023

Mucosal Leishmaniasis Trial in Santa Cruz de la Sierra (Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal

Recruiting
  • Mucosal Leishmaniasis
  • Group 1: Miltefosine
  • +2 more
  • Santa Cruz de la Sierra, SC, Bolivia
    Hospital Dermatologico de Jorochito
Jun 14, 2022

Pulmonary Mucormycosis Trial in Chandigarh (Inhaled amp B deoxycholate+intravenous liposomal amp B, Intravenous liposomal

Completed
  • Pulmonary Mucormycosis
  • Inhaled amp B deoxycholate+intravenous liposomal amp B
  • Intravenous liposomal amphotericin B alone
  • Chandigarh, India
    Post graduate Institute medical education and research
Jan 24, 2022

Histoplasmosis, AIDS Trial in Porto Alegre (single dose of L-AmB, 2 doses of L-AmB, 2 weeks of L-AmB)

Recruiting
  • Histoplasmosis
  • AIDS
  • single dose of L-AmB
  • +2 more
  • Porto Alegre, Rio Grande Do Sul, Brazil
    Irmandade da Santa Casa de Misericórdia de Porto Alegre
Jul 12, 2021

Morbid Obesity Trial in Nijmegen, Nieuwegein (Administration of study drug)

Completed
  • Morbid Obesity
  • Administration of study drug
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Oct 16, 2020

Cryptococcal Meningitis Trial in Kampala (Single dose liposomal Amphotericin and Fluconazole, Fluconazole)

Recruiting
  • Cryptococcal Meningitis
  • Single dose liposomal Amphotericin and Fluconazole
  • Fluconazole
  • Kampala, Uganda
    infectious Disease Institute Kampala,Uganda
Dec 21, 2022

Clinical Benefits of Different Formulations of Amphotericin B

Active, not recruiting
  • Efficacy
  • Safety
    • Jinan, Shandong, China
      Rui Yang,MD
    Nov 3, 2023

    Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)

    Active, not recruiting
    • Bioequivalence
    • Amphotericin B liposome for injection
    • AmBisome
    • Haikou, Hainan, China
      Haikou people's Hospital
    Jun 12, 2023

    The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal

    Completed
    • Fungal Infection
    • Deoxycholic acid amphotericin B
    • Nanjing, Jiangsu, China
    • +1 more
    Nov 29, 2022

    Invasive Pulmonary Aspergillosis Trial in Madrid (Amphotericin B Liposomal 50 MG, Placebo)

    Recruiting
    • Invasive Pulmonary Aspergillosis
    • Amphotericin B Liposomal 50 MG
    • Placebo
    • Madrid, Spain
      Jesus Fortun
    Feb 2, 2021

    Allergic Bronchopulmonary Aspergillosis Trial in Poitiers (Liposomal amphotericin B (Ambisome®), )

    Completed
    • Allergic Bronchopulmonary Aspergillosis
    • Liposomal amphotericin B (Ambisome®)
    • placebo
    • Poitiers, France
      Chu de Poitiers
    Jun 8, 2020

    Cryptococcal Meningitis Trial in Kampala (MAT2203, Amphotericin B)

    Active, not recruiting
    • Cryptococcal Meningitis
    • Kampala, Uganda
      Infectious Disease Institute
    Nov 16, 2022

    Candidiasis, Chronic Mucocutaneous Trial run by the Matinas BioPharma Nanotechnologies, Inc. (Amphotericin B)

    Completed
    • Candidiasis, Chronic Mucocutaneous
    • Amphotericin B
    • Bethesda, Maryland
      National Institute of Allergy and Infectious Disease (NIAID)
    Aug 17, 2022

    Invasive Candidiasis, Invasive Aspergillosis Trial in Tianjin (Amphotericin B cholesteryl Sulfate Complex for Injection)

    Not yet recruiting
    • Invasive Candidiasis
    • Invasive Aspergillosis
    • Amphotericin B cholesteryl Sulfate Complex for Injection
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Jan 29, 2023

    Cryptococcal Meningitis Trial (MAT2203, Amphotericin B)

    Not yet recruiting
    • Cryptococcal Meningitis
    • (no location specified)
    Sep 12, 2022

    Amphotericin B With Flucytosine-Fluconazole Therapy for

    Completed
    • Cryptococcal Meningitis
    • Amphotericin B 1 mg/kg 1 week & Flucytosine 100 mg/kg 1 week followed by Fluconazole 1200 mg/day 1 week
    • Yangon, Myanmar
      Specialist hospital Mingalardon,Thakeyta and Waibargi,Yangon Gen
    Apr 20, 2022

    Neutropenia and Fever Trial (Amphotericin B liposomes)

    Not yet recruiting
    • Neutropenia and Fever
    • Amphotericin B liposomes
    • (no location specified)
    Nov 1, 2021

    Safety of ABCD in the Treatment of IFD

    Recruiting
    • Invasive Fungal Disease
    • Amphotericin B colloidal dispersion（ABCD）
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Oct 20, 2022

    Cryptococcal Meningitis Trial in Beijing (Amphotericin B Colloidal Dispersion, flucytosine, fluconazole)

    Not yet recruiting
    • Cryptococcal Meningitis
    • Amphotericin B Colloidal Dispersion
    • +2 more
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 20, 2022

    Invasive Aspergillosis Trial in Pathum Wan (Olorofim, AmBisome®)

    Recruiting
    • Invasive Aspergillosis
    • Sacramento, California
    • +44 more
    Dec 16, 2022

    Cystic Fibrosis Trial in Christchurch (ABCI, Placebo)

    Recruiting
    • Cystic Fibrosis
    • ABCI
    • Placebo
    • Christchurch, New Zealand
      New Zealand Clinical Research
    Apr 4, 2023

    Bioequivalence Trial in Wuhan (Amphotericin B liposome for injection, AmBisome®)

    Completed
    • Bioequivalence
    • Wuhan, Hubei, China
      Wuhan Medical Treatment Center
    Jul 28, 2021